Summary - Management of women with abnormal cervical cytology

These national guidelines are intended for use by health professionals who manage patients with abnormal cytology: gynecologists, colposcopists, pathologists, virologists, microbiologists, midwives and general practitioners.

Patients concerned by these guidelines are those eligible for the French cervical cancer screening program, who are immunocompetent and aged 25-657. Based on current knowledge, the management will be similar for immunized and non-immunized women. Immunosuppressed women are not concerned by these guidelines.

(1 MB)
  • Collection : Recommandations et référentiels
  • Public : Professionnels de santé
  • Date de publication :
  • Référence : RREFCCUPLEN2016
  • Format : Brochure A4
  • Langue : Français